Nexalin Technology Files S-1/A Amendment

TL;DR

Nexalin Tech filed an S-1/A, looks like they're still pushing for that IPO.

AI Summary

Nexalin Technology, Inc. filed an S-1/A amendment on June 14, 2024, for its initial public offering. The company, incorporated in Delaware with its principal executive offices in Houston, TX, is in the electromedical and electrotherapeutic apparatus industry. This filing is an amendment to a previous registration statement.

Why It Matters

This S-1/A filing indicates Nexalin Technology, Inc. is moving forward with its public offering, which could provide capital for its operations and expansion in the medical device sector.

Risk Assessment

Risk Level: medium — As an S-1/A filing, it pertains to an initial public offering, which inherently carries risks associated with new market entrants and unproven business models.

Key Numbers

• 333-279684 — SEC Registration Number (Identifies this specific registration filing with the SEC.)
• 3845 — SIC Code (Indicates the company operates in the Electromedical & Electrotherapeutic Apparatus industry.)

Key Players & Entities

• Nexalin Technology, Inc. (company) — Registrant
• June 14, 2024 (date) — Filing date
• 333-279684 (registration_number) — SEC Registration Number
• Mark White (person) — Chief Executive Officer
• 1776 Yorktown, Suite 550 Houston, TX 77056 (address) — Principal Executive Offices
• 3845 (sic_code) — Standard Industrial Classification Code

FAQ

Key Financial Figures

• $7,000,000 — CTUS NEXALIN TECHNOLOGY, INC. Up to $7,000,000 of Common Stock We are offering on a
• $0.001 — s up to $7,000,000 of our common stock, $0.001 par value per share. We are offering ea
• $1.38 — aq Capital Market on June 13, 2024, was $1.38 per share. We are an “emerging
• $5,783 — ASC 810”), the Company recognized $5,783 of equity method investment income from
• $101,783 — pany had an Equity Method Investment of $101,783 and $96,000, respectively, reco
• $96,000 — quity Method Investment of $101,783 and $96,000, respectively, reco

Filing Documents

• nexalintech_s1a.htm (S-1/A) — 650KB
• nexalintech_ex1-2.htm (EX-1.2) — 109KB
• nexalintech_ex5-1.htm (EX-5.1) — 9KB
• nexalintech_ex10-15.htm (EX-10.15) — 26KB
• nexalintech_ex10-16.htm (EX-10.16) — 189KB
• nexalintech_ex23-1.htm (EX-23.1) — 2KB
• nexalintech_ex107.htm (EX-FILING FEES) — 29KB
• img_001.jpg (GRAPHIC) — 7KB
• ex5-1_001.jpg (GRAPHIC) — 4KB
• 0001829126-24-004207.txt ( ) — 1031KB

RISK FACTORS

RISK FACTORS 17 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA 52

USE OF PROCEEDS

USE OF PROCEEDS 54 DIVIDEND POLICY 55 CAPITALIZATION 56

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 58 PLAN OF DISTRIBUTION 61 LEGAL MATTERS 66 EXPERTS 66 WHERE YOU CAN FIND ADDTIONAL INFORMATION 66 INCORPORATION OF CERTAIN INORMATION BY REFERENCE 67 You should rely only on the information contained in this prospectus or any prospectus supplement or amendment. Neither we, nor the Placement Agent, have authorized any other person to provide you with information that is different from, or adds to, that contained in this prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. Neither we nor the Placement Agent take responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. You should assume that the information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. We are not making an offer of any securities in any jurisdiction in which such offer is unlawful. No action is being taken in any jurisdiction outside the United States to permit a public offering of our securities or possession or distribution of this prospectus in that jurisdiction. Persons who come into possession of this prospectus in jurisdictions outside the United States are required to inform themselves about and to observe any restrictions as to this public offering and the distribution of this prospectus applicable to that jurisdiction. i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (“SEC”). It omits some of the information contained in the registration statement and reference is made to the registration statement for further information with regard to us and the securities being offered hereby. You sho

View Full Filing

View this S-1/A filing on SEC EDGAR